Portfolio

Amedrix Exit

Amedrix develops & produces three dimensional implants (gel and liquid) based on collagen. Focus: treatment of articular cartilage damage in human an horse and other promising application areas. CE-mark for the cartilage repair product is granted & successfully used in patients.

Pressemeldungen

High-Tech Gruenderfonds and Life Science Fonds Esslingen invest in Amedrix GmbH

Amedrix GmbH announces that High-Tech Gruenderfonds (HTGF) and Life Science Fonds Esslingen jointly invested a total of 700,000 Euro in the newly founded company. Amedrix GmbH develops and produces acellular implants based on a collagen type I matrix as medical devices for human and veterinarian purposes. The great…
Read

Info & Contact

Dr. Thomas Graeve
Phone:
+49 711 93341450
Web:
www.amedrix.de

Address

Schelztorstraße 54-56
73728 Esslingen

In portfolio

01. Dec 2009 – 15. Jul 2013
Exit